Evolving epidemiology of Pseudomonas aeruginosa and the Burkholderia cepacia complex in cystic fibrosis lung infection.
about
Antibiotic treatment for Burkholderia cepacia complex in people with cystic fibrosis experiencing a pulmonary exacerbationAntibiotic treatment for Burkholderia cepacia complex in people with cystic fibrosis experiencing a pulmonary exacerbationProperties of PASP: a Pseudomonas protease capable of mediating corneal erosionsRefinement of OprH-LPS Interactions by Molecular Simulations.Molecular Interactions of Lipopolysaccharide with an Outer Membrane Protein from Pseudomonas aeruginosa Probed by Solution NMR.OprG Harnesses the Dynamics of its Extracellular Loops to Transport Small Amino Acids across the Outer Membrane of Pseudomonas aeruginosaVirulence and cellular interactions of Burkholderia multivorans in chronic granulomatous disease.Susceptibility of Caenorhabditis elegans to Burkholderia infection depends on prior diet and secreted bacterial attractantsFucofullerenes as tight ligands of RSL and LecB, two bacterial lectins.Monocytes from cystic fibrosis patients are locked in an LPS tolerance state: down-regulation of TREM-1 as putative underlying mechanism.Gene expression changes linked to antimicrobial resistance, oxidative stress, iron depletion and retained motility are observed when Burkholderia cenocepacia grows in cystic fibrosis sputumAssessment of three Resistance-Nodulation-Cell Division drug efflux transporters of Burkholderia cenocepacia in intrinsic antibiotic resistance.Pseudomonas aeruginosa LPS or flagellin are sufficient to activate TLR-dependent signaling in murine alveolar macrophages and airway epithelial cells.Exploring the HME and HAE1 efflux systems in the genus BurkholderiaEntry of Burkholderia organisms into respiratory epithelium: CFTR, microfilament and microtubule dependence.Development of real-time PCR assays for detection of the Streptococcus milleri group from cystic fibrosis clinical specimens by targeting the cpn60 and 16S rRNA genesVirulence traits associated with Burkholderia cenocepacia ST856 epidemic strain isolated from cystic fibrosis patients.The changing microbial epidemiology in cystic fibrosis.Identification of hopanoid biosynthesis genes involved in polymyxin resistance in Burkholderia multivoransFosmidomycin decreases membrane hopanoids and potentiates the effects of colistin on Burkholderia multivorans clinical isolatesGenomic expression analysis reveals strategies of Burkholderia cenocepacia to adapt to cystic fibrosis patients' airways and antimicrobial therapy.Factors influencing acquisition of Burkholderia cepacia complex organisms in patients with cystic fibrosis.Biocide susceptibility of the Burkholderia cepacia complex.Low rates of Pseudomonas aeruginosa misidentification in isolates from cystic fibrosis patients.Management of refractory Pseudomonas aeruginosa infection in cystic fibrosisAmgRS-mediated envelope stress-inducible expression of the mexXY multidrug efflux operon of Pseudomonas aeruginosa.The quorum-sensing molecules farnesol/homoserine lactone and dodecanol operate via distinct modes of action in Candida albicansSwimming motility in a longitudinal collection of clinical isolates of Burkholderia cepacia complex bacteria from people with cystic fibrosis.Garlic revisited: antimicrobial activity of allicin-containing garlic extracts against Burkholderia cepacia complex.Chronic Infection by Mucoid Pseudomonas aeruginosa Associated with Dysregulation in T-Cell Immunity to Outer Membrane Porin FComplete genome sequence of Pseudomonas aeruginosa lytic bacteriophage PA1O which resembles temperate bacteriophage D3112.Whole-Genome Sequencing of Three Clonal Clinical Isolates of B. cenocepacia from a Patient with Cystic FibrosisTwo case reports of the successful eradication of new isolates of Burkholderia cepacia complex in children with cystic fibrosisLong-term colonization of the cystic fibrosis lung by Burkholderia cepacia complex bacteria: epidemiology, clonal variation, and genome-wide expression alterations.Can early Burkholderia cepacia complex infection in cystic fibrosis be eradicated with antibiotic therapy?Comparative genomics of Burkholderia multivorans, a ubiquitous pathogen with a highly conserved genomic structure.SNaPBceBcon: a Practical Tool for Identification and Genotyping of Burkholderia cepacia and Burkholderia contaminansBurkholderia cepacia complex bacteria: opportunistic pathogens with important natural biology.Chemical and biological features of Burkholderia cepacia complex lipopolysaccharides.Long-Term Evolution of Burkholderia multivorans during a Chronic Cystic Fibrosis Infection Reveals Shifting Forces of Selection
P2860
Q24198135-7DEF1074-92A1-41D0-9EA6-6CACB093D33BQ24234854-38255DDF-9FAC-475D-BC94-3C3F0D10053FQ24607872-B4C53112-29E0-40A3-9C1F-C9F587438AE8Q30274925-48DD2140-0A56-42DA-9D76-73FB68AB15D9Q30276105-DF2F39A8-892B-4DE6-A364-A9B5F3A3C49FQ30277922-312B9285-DA81-44CF-9613-1DBF91E49A66Q30436584-B2AE3B9E-0A7F-44B6-BEAF-36660F22F7B7Q30946114-2E32E558-27C1-40DF-9E8E-F91DCA627228Q30950389-C9A4348D-9BF4-4133-BAC6-CDC0720632B0Q33352036-9332ADE8-E9C8-47E6-897C-46D883E761BDQ33370443-A5D92CAD-EC5F-4A81-95FC-B84D4CA856ACQ33504396-9CA4A728-14BA-43A7-BDED-5D01BC01D603Q33508834-E5F3430D-F178-4668-948A-B72F8063DC28Q33595044-F2C413F5-B874-40D2-91E7-7E96B9C8B813Q33637302-06CB1073-087A-40FF-9290-CA59B69397BEQ33769617-B1D11C8D-8110-46B0-9EF9-4FCD4EEBF787Q33771827-0F488443-5142-41CF-9757-9103809797E4Q33825634-BA5F17D1-5527-485B-AAB4-73E324F66B8FQ34049989-135AFA72-F2E2-47CB-B9D3-B60B84140DA0Q34057514-7A13E1A3-5F07-4861-8D1E-6291C5DB07E3Q34117003-51102163-F629-4170-B346-2D5B08DC90C8Q34372132-B4CE8C61-A7E7-433C-B027-A4F2217A3D5AQ34924879-84717671-4050-4CBA-BC68-7D28448DE442Q34956792-0953D8EB-EDB0-4075-82EF-3F1DEC532E3FQ35026630-32A707A1-0FBB-4D7F-9858-7D75342C7E30Q35106217-F5CDBA1D-ADD5-4C9A-833A-A51F85D82D9FQ35191796-DC44F29E-F1B4-4C57-87D6-92C3D2D32FC7Q35244339-9C9D916A-0859-4632-9E7B-F4FF53849350Q35464431-96D96320-A017-4F71-976A-F9EAE6EC459FQ35766685-D7A44038-F30A-4737-B0B4-C25BF4F25993Q35826292-4923F02A-DAB3-4BB1-835B-170517710780Q35849996-1D15B9A7-8CA7-4E5D-A0AE-37FFCFEDA0B9Q35971108-EA57D674-82EF-46F3-A23B-7DFDA8FCAFDFQ36158775-B3BA7FA4-2EB4-44DF-A509-EE97294D01EFQ36158785-978A0778-91D1-4320-87B6-13D9E9311D75Q36353545-92AD337B-0498-48FB-99E7-85F19144CF76Q36521306-504C3120-4064-4D5B-9A2F-7BC536040BC3Q37064461-B2EC2D02-9F3F-419D-9D40-B357603CDF98Q37194242-90432296-966A-44BF-8362-0C5A4A0BA49AQ37349255-D38C61AF-9BDB-444D-8D68-AC35AFFD3903
P2860
Evolving epidemiology of Pseudomonas aeruginosa and the Burkholderia cepacia complex in cystic fibrosis lung infection.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Evolving epidemiology of Pseud ...... ystic fibrosis lung infection.
@en
type
label
Evolving epidemiology of Pseud ...... ystic fibrosis lung infection.
@en
prefLabel
Evolving epidemiology of Pseud ...... ystic fibrosis lung infection.
@en
P2093
P2860
P356
P1433
P1476
Evolving epidemiology of Pseud ...... ystic fibrosis lung infection.
@en
P2093
Alan R Brown
Andrew M Jones
John R W Govan
P2860
P304
P356
10.2217/17460913.2.2.153
P577
2007-04-01T00:00:00Z